Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO local/national coverage decisions report

This article was originally published in The Gray Sheet

Executive Summary

Jan. 31, 2003 targeted as General Accounting Office's submission date to Senate Finance Committee Chairman Max Baucus (D-Mont.), Ranking Member Chuck Grassley (R-Iowa) and Special Committee on Aging Chairman John Breaux (D-La.). The report will analyze local and national coverage trends for new procedures and devices (1"The Gray Sheet" Jan. 21, 2002, In Brief)...

You may also be interested in...



Device coverage policy

General Accounting Office plans to release a report on coverage decisions for new procedures and devices in June, in time to influence congressional debate over Medicare reform legislation, Health Care-Program Administration & Integrity Issues Director Leslie Aronowitz tells HHS secretary's regulatory reform committee in Washington, D.C. Jan. 7. Initiated by GAO, the study will examine the national coverage process, local carrier decisions, and the "hundreds and hundreds of [CPT and HCPCS] codes that get assimilated into the payment system without any formal [coverage] process. We need to understand the extent to which this happens and the rationale that underlies the different pathways," she says...

The COVID-19 Effect: Medicare Part B Oncology Drug Claims Down 40% Through April

Study commissioned by the PhRMA underscores concerns about how the coronavirus has disrupted use of physician-administered drugs.

NCI Is Being 'Flexible' With COVID-19 Clinical Trial Protocols

At ASCO symposium on cancer care during the pandemic, NCI Director Ned Sharpless notes trial accrual at NCI's National Clinical Trials Network dropped by half in March and April.

UsernamePublicRestriction

Register

AP015708

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel